Related references
Note: Only part of the references are listed.DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Epigenetic inactivation of tumour suppressor gene KLF11 in myelodysplastic syndromes
Anna Potapova et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia
S. Deneberg et al.
LEUKEMIA (2010)
Study of specific genetic and epigenetic variables in multiple myeloma
Eleftheria Hatzimichael et al.
LEUKEMIA & LYMPHOMA (2010)
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang et al.
BLOOD (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
The p53 target Plk2 interacts with TSC proteins impacting mTOR signaling, tumor growth and chemosensitivity under hypoxic conditions
Elizabeth M. Matthew et al.
CELL CYCLE (2009)
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
Soheil Meshinchi et al.
CLINICAL CANCER RESEARCH (2009)
Association between polymorphisms of folate-metabolizing enzymes and hematological malignancies
Hee Nam Kim et al.
LEUKEMIA RESEARCH (2009)
Mechanisms of Disease: Myelodysplastic Syndromes.
Ayalew Tefferi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
Heike Kroeger et al.
BLOOD (2008)
Plk2 regulated centriole duplication is dependent on its localization to the centrioles and a functional polo-box domain
Onur Cizmecioglu et al.
CELL CYCLE (2008)
Genetic susceptibility to cancer - The role of polymorphisms in candidate genes
Linda M. Dong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Cooperating gene mutations in acute myeloid leukemia: a review of the literature
A. Renneville et al.
LEUKEMIA (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Epigenetic regulation of normal and malignant hematopoiesis
K. L. Rice et al.
ONCOGENE (2007)
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gene silencing by DNA methylation in haematological malignancies
Jacqueline Boultwood et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Role of MTHFR (677,1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies
V. M. Guillem et al.
LEUKEMIA (2007)
Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia
Pascual Bolufer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference
Peter Valent et al.
LEUKEMIA RESEARCH (2007)
Clinical implications of SOCS1 methylation in myelodysplastic syndrome
Shang-Ju Wu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3
Paul Smith et al.
CELL CYCLE (2006)
Polo-like kinases - A team in control of the division
Barbara C. M. van de Weerdt et al.
CELL CYCLE (2006)
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
N Syed et al.
BLOOD (2006)
Genetics of myeloid malignancies:: Pathogenetic and clinical implications
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
DNA methylation and human disease
KD Robertson
NATURE REVIEWS GENETICS (2005)
Centrosome aberrations in hematological malignancies
A Krämer et al.
CELL BIOLOGY INTERNATIONAL (2005)
Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues
JA Winkles et al.
ONCOGENE (2005)
Polo-like kinases and oncogenesis
F Eckerdt et al.
ONCOGENE (2005)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Role of Plk2 (Snk) in mouse development and cell proliferation
S Ma et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg
M Esteller
CLINICAL IMMUNOLOGY (2003)
Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (Taxol)-exposed cells
TF Burns et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Alterations of DNA methylation in hematologic malignancies
LJ Rush et al.
CANCER LETTERS (2002)
Share Paper
